Posts

Vitrakvi approved for NTRK+ cancers | MyOncoPath
0 Comments
/
FDA approves Vitrakvi in all tumor types with NTRK gene variants
Progress…

FDA Finalizes Next Generation Sequencing Genetic Tests to Accelerate Reliable Development
FDA finalizes guidances to accelerate the development of reliable,…

FoundationOne CDx Comprehensive Genomic Profiling for Solid Tumors Now Commercially Available
Foundation Medicine Announces Commercial Availability of FoundationOne…

Keytruda Immunotherapy FDA Approval - Cancer Treatment for Tumors with Specific Genetic Markers
In May 2017 the FDA granted accelerated approval to an immunotherapy…

FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers
